Any patient who was diagnosed with a C. diff infection within 30 days of antibiotic treatment was presumed to have antibiotic-associated C. diff. About 87% of patients were treated with ...

The antibiotic vancomycin, recommended as first-line treatment for infection caused by the deadly superbug C. difficile (C. diff), may not be living up to its promise, according to new research.

For this study, researchers examined data from more than 10,000 patients treated for C. diff infections through the Department of Veterans Affairs healthcare system between 2005 and 2012.

Fecal microbiota transplant might be considered for first-line treatment of Clostridioides difficile (C. diff), based on noninferiority findings from a randomized, open-label trial. A similar ...

During the 1980s and 1990s, the antibiotic metronidazole was successfully used to treat C. diff infections. Back then, metronidazole had a greater than 90% success rate, but that has declined ...

The article points out improved hospital and community-wide antibiotic stewardship efforts to combat the spread of C. diff infections are called for by the CDC, the Society for Healthcare ...

The antibiotic vancomycin, recommended as first-line treatment for infection caused by the deadly superbug C. difficile (C. diff), may not be living up to its promise, according to new research ...

A new study on Clostridioides difficile infections finds that choosing an alternative antibiotic for high-risk patients with pneumonia can reduce infection risk. C. diff infections can be deadly ...

When those bacteria die — for instance, as a result of antibiotic treatment for an unrelated infection — the large intestine becomes vulnerable, and this is often when C. difficile strikes.